Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/27/2025

Diagnosis and Management of Venous Thromboembolism

Initial Evaluation and Testing

  • For patients with elevated D-dimer but negative CT chest for pulmonary embolism and negative ultrasound for DVT, no further testing is recommended due to the high negative predictive value of these combined tests, as per the American College of Chest Physicians (ACCP) guidelines 1
  • A combination of negative proximal compression ultrasound (CUS) and negative CT chest has excellent negative predictive value, and the ACCP guidelines recommend no further testing in this scenario 1
  • When clinical suspicion remains high despite negative initial tests, consideration for isolated iliac vein thrombosis is recommended, and MR venography or CT venography may be considered if iliac vein thrombosis is suspected 1

Upper Extremity DVT Evaluation

  • Combined-modality ultrasound (compression with Doppler) is the preferred initial test for clinically suspected upper extremity DVT, as recommended by the ACCP guidelines 1
  • If initial ultrasound is negative but clinical suspicion remains high, venography or MRI may be considered for further evaluation 1

Avoiding Unnecessary Testing and Treatment

  • Additional testing generally adds cost without clinical benefit when both CT chest and DVT ultrasound are negative, according to the ACCP guidelines 1
  • Elevated D-dimer levels can be associated with various non-thrombotic conditions, including:

Anticoagulation and Management

  • Anticoagulation should be initiated according to specific guidelines for patients with identified venous or arterial thrombosis, with the ACCP recommending anticoagulation for TEV 1
  • For patients with cerebral venous sinus thrombosis (TVC), anticoagulation with low molecular weight heparin followed by oral anticoagulants is recommended by the American Heart Association/American Stroke Association 2
  • In patients with chronic liver disease, serial monitoring of coagulation tests and evaluation for portal vein thrombosis if D-dimer is markedly elevated are recommended by the European Association for the Study of the Liver 4
  • Prophylactic anticoagulation is not recommended based solely on elevated D-dimer levels in patients with chronic liver disease, according to the European Association for the Study of the Liver 4
  • Isolated elevation of D-dimer without clinical symptoms does not require routine anticoagulation, as stated by the ACCP 1

Follow-up and Monitoring

  • Follow-up should be individualized based on the identified underlying cause, with more frequent monitoring in patients at higher risk of thrombotic or hemorrhagic events, as recommended by the European Society of Cardiology 4
  • Serial evaluations of D-dimer levels and cardiovascular risk assessment should be considered in patients without an identified cause but with persistent significant elevation, according to the European Association for the Study of the Liver 4